QuidelOrtho (QDEL)
(Delayed Data from NSDQ)
$41.05 USD
-0.92 (-2.19%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $41.04 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$41.05 USD
-0.92 (-2.19%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $41.04 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth C Momentum C VGM
Zacks News
Quidel (QDEL) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Quidel (QDEL) delivered earnings and revenue surprises of 66.07% and 0.18%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Medical Products Stock Earnings on Jul 30: BAX, SYK & More
by Trina Mukherjee
Despite the impact of the pandemic on the second quarter, Medical Product companies have shown strength on the back of huge adoption of COVID-19 related healthcare-support products and services.
Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FNY
Should iShares Morningstar SmallCap Growth ETF (JKK) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JKK
Quidel (QDEL) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Quidel (QDEL) closed at $255.51 in the latest trading session, marking a -0.67% move from the prior day.
Quidel (QDEL) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Quidel (QDEL) is likely to have witnessed an uptick in rapid immunoassay revenues in Q2.
Quidel (QDEL) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Quidel (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quidel (QDEL) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Quidel (QDEL) closed at $242.73, marking a -1.4% move from the previous day.
Quidel (QDEL) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Quidel (QDEL) closed at $246.64 in the latest trading session, marking a +0.69% move from the prior day.
3 Reasons Why Growth Investors Shouldn't Overlook Quidel (QDEL)
by Zacks Equity Research
Quidel (QDEL) possesses solid growth attributes, which could help it handily outperform the market.
AdaptHealth (AHCO) Catches Eye: Stock Jumps 6.5%
by Zacks Equity Research
AdaptHealth (AHCO) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Is Quidel (QDEL) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (QDEL) Outperforming Other Medical Stocks This Year?
Quidel (QDEL) Catches Eye: Stock Jumps 6.3%
by Zacks Equity Research
Quidel (QDEL) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
5 Stocks to Fight Volatility Stemming From the Coronavirus Spike
by Sreoshi Bera
Investing in stocks from defensive sectors like utilities, healthcare and consumer staples and remote working can prove prudent in the current market scenario.
Quidel, Keysight Technologies, Adobe, Nvidia and Zoom Video as Zacks Bull and Bear of the Day
by Zacks Equity Research
Quidel, Keysight Technologies, Adobe, Nvidia and Zoom Video as Zacks Bull and Bear of the Day
Bull of the Day: Quidel (QDEL)
by Kevin Cook
Multiple FDA approvals for new 15-minute COVID-19 antigen tests have estimates and shares rising sharply
The Zacks Analyst Blog Highlights: Zoom Video, Quidel, Zscaler, Datadog and Novavax
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Zoom Video, Quidel, Zscaler, Datadog and Novavax
5 Must-Buy Stocks No Matter What Shape Recovery Takes
by Aniruddha Ganguly
Here we discuss five stocks that have gained more than 25% year to date and are well-poised to grow further, irrespective of the shape the economy takes to recover from COVID-19-induced recession.
5 Top-Ranked Stocks That Made Nasdaq Outperform in 1H
by Sweta Killa
The tech-heavy Nasdaq Composite Index has outperformed so far this year, having gained 12% in comparison to losses of 3.5%for the S&P 500 and 8.8% for Dow Jones.
5 Nasdaq Stocks That Have Returned More Than 100% YTD
by Aniruddha Ganguly
Here we discuss five Nasdaq-listed stocks that have gained more than 100% year to date and are well-poised to grow further on solid prospects.
3 Reasons Why Quidel (QDEL) Is a Great Growth Stock
by Zacks Equity Research
Quidel (QDEL) possesses solid growth attributes, which could help it handily outperform the market.
Will Quidel Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor of Quidel
The Zacks Analyst Blog Highlights: Tesla, Quidel, Datadog, Beyond Meat and DocuSign
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Tesla, Quidel, Datadog, Beyond Meat and DocuSign
Is Quidel (QDEL) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (QDEL) Outperforming Other Medical Stocks This Year?
5 High-Flying Stocks of Last Week That Defied Market Turmoil
by Nalak Das
Not all stocks succumbed to last week's market rout that ended the more than 10-week long rally. A few stocks popped last week.